Demystifying the Financial Backbone of Life Sciences Commercialization

Gross-to-Net (GTN) touches nearly every part of commercialization, yet it remains one of the most misunderstood and under-optimized areas in life sciences.

Our new guide, “Gross-to-Net 101,” offers clear, actionable insights into:

• Why GTN isn’t just accounting – it’s strategic
• Where most teams go wrong, and how to prevent it
• How to build models that evolve with your portfolio and the market
• What Riparian’s lifecycle-based GTN support looks like in practice